<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25054761</article-id>
      <article-id pub-id-type="pmc">4148288</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20142802</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Imaging In Dermatology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Polypoid melanoma and superficial spreading melanoma different
subtypes in the same lesion<sup><xref ref-type="fn" rid="fn01">*</xref></sup>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hikawa</surname>
            <given-names>Renato Shintani</given-names>
          </name>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kanehisa</surname>
            <given-names>Eliza Sayuri</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Enokihara</surname>
            <given-names>M&#xED;lvia Maria Sim&#xF5;es e Silva</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Enokihara</surname>
            <given-names>Mauro Yoshiaki</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hirata</surname>
            <given-names>S&#xE9;rgio Henrique</given-names>
          </name>
        </contrib>
        <aff> Universidade Federal de S&#xE3;o Paulo (UNIFESP) - S&#xE3;o Paulo (SP), Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Renato Shintani Hikawa, Rua Borges Lagoa, 508 -
Vila Clementino, 04038-001 - S&#xE3;o Paulo - SP, Brazil. E-mail:
<email>renato71@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Aug</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Aug</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>4</issue>
      <fpage>666</fpage>
      <lpage>668</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>5</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>7</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Melanoma is a malignant melanocytic neoplasm with high mortality rate, and
steadily and universally increasing incidence rates. Polypoid melanoma is
considered an exophytic variant of the nodular subtype. The incidence of
polypoid melanoma is extremely variable, most likely because of the different
criteria used for its characterization. We presented a rare case of polypoid
melanoma and superficial spreading melanoma in the same lesion.</p>
      </abstract>
      <kwd-group>
        <kwd>Dermatology</kwd>
        <kwd>Dermoscopy</kwd>
        <kwd>Melanoma</kwd>
        <kwd>Skin neoplasms</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Melanoma is a malignant melanocytic neoplasm which still maintains a high mortality
rate and incidence rates that have been universally increasing over the past few
years.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> Four subtypes of
melanoma are classically recognized by using clinical and pathological criteria:
superficial spreading, lentigo maligna, acral lentiginous and nodular. This
classification allows the clinicopathological tumor differentiation, but not its
categorization according to different prognosis.<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref></sup> The prognosis of
the primary tumor is closely related to its thickness (Breslow), presence of
ulceration and, more recently, the presence of 1 or more mitosis/mm<sup><xref rid="r02" ref-type="bibr">2</xref></sup> in thin melanomas.<sup><xref rid="r04" ref-type="bibr">4</xref></sup> Polypoid melanoma is considered an
exophytic variant of the nodular form in which the volume of the tumor is located
above the skin surface, and it may be pedunculated or sessile. It often appears
ulcerated but not necessarily pigmented, which may cause it to be mistaken by benign
lesions such as pyogenic granuloma, intradermal nevus, or fibroepithelial
polyp.<sup><xref rid="r05" ref-type="bibr">5</xref></sup> We present a rare
case of polypoid melanoma overlapping the area of a superficial spreading
melanoma.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A fifty-eight year-old patient reported a pigmented lesion in the left lumbar region
for many years, with progressive growth. Three months before he noticed accelerated
growth and ulceration of the lesion. Dermatological examination found a pigmented
asymmetric macule, with irregular borders, multiple colors, measuring 3x2 cm in the
left lumbar region. In the lower right area of the lesion there was an erythematous,
friable polypoid formation of approximately 1 cm, ulcerated and covered by a
serohematic crust (<xref ref-type="fig" rid="f01">Figure 1</xref>). Dermatoscopy
showed that the pigmented lesion was formed by a multicomponent pattern with
presence of an atypical network, irregular globules and blotches, all irregularly
distributed throughout the lesion (<xref ref-type="fig" rid="f02">Figure 2</xref>).
The presence of serohematic crust made it difficult to visualize the dermoscopic
pattern on the polypoid area. Pathologic examination revealed polypoid superficial
spreading melanoma, Clark III, Breslow thickness of 4.3 mm at the polypoid area and
predominant <italic>in situ </italic>component in adjacent skin (<xref ref-type="fig" rid="f03">Figure 3</xref>). The exam also showed absence of
ulceration or regression and the presence of 8 mitoses in 10 high power fields.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p><bold>A</bold>: Clinical aspect of the lesion on the lumbar area;
<bold>B</bold>: Detailed image showing the polypoid conformation of the
lesion</p>
        </caption>
        <graphic xlink:href="abd-89-04-0666-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p><bold>A</bold>: Atypical network, multifocal hyperpigmentation with irregular
distribution, presence of a bluish-gray veil; <bold>B</bold>: Blackish-brown
globules irregularly distributed throughout the lesion, multifocal
pigmentation and bluish-gray veil.</p>
        </caption>
        <graphic xlink:href="abd-89-04-0666-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p><bold>A</bold>: Polypoid melanoma pedicle on the insertion area. The adjacent
skin surface shows slight proliferation of typical and atypical melanocytes
in the basal layer and lymphocytic inflammatory infiltrate in the
superficial dermis (HE, 40x); <bold>B</bold>: Proliferation of atypical
melanocytic cells with severe atypia and pagetoid appearance (HE, 400x);
<bold>C</bold>: Top of the polypoid area showing epidermis and dermis
with proliferation of atypical melanocytes and areas of necrosis (HE
100x)</p>
        </caption>
        <graphic xlink:href="abd-89-04-0666-g03"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The pedunculated melanoma was first described in 1958 by Vogler <italic>et
</italic>al, who considered it as the most aggressive form of nodular melanoma, with
almost nonexistent radial growth, followed by rapid vertical growth, creating its
pedunculated conformation. It was, by definition, a tumor with more than 50% of its
area above the epidermis and lateral dissemination inferior to three intraepidermal
crests.<sup><xref rid="r06" ref-type="bibr">6</xref></sup> McGovern
<italic>et al</italic>, in 1983 classified the polypoid melanoma into
pedunculated or sessile. The pedunculated form was defined as a lesion completely
above an unaltered cutaneous surface, with which it was connected by a pedicle. The
sessile form would have at least 50% of the tumor above the surface. The incidence
of polypoid melanoma is extremely variable in the literature, ranging from 2 to 43%
in different studies, probably due to different clinical and pathological criteria
used to characterize it. It was believed to be the most aggressive form of melanoma
with the worst prognosis. However, multivariate analysis showed that this behavior
was not explained by the lesion conformation <italic>per se</italic>, but rather
because this form of melanoma was usually thicker and ulcerated. Clinically, it
evolves with rapid growth and histopathologically it has a higher degree of cellular
atypia, nuclear and cellular pleomorphism and higher mitotic index that can also
explain the apparent poor prognosis.<sup><xref rid="r07" ref-type="bibr">7</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup></p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>We present a rare case of polypoid melanoma over an area of superficial spreading
melanoma. The case highlights the importance of prognostic factors linked to
melanoma, independent of histological subtype.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p> Work performed at the Universidade Federal de S&#xE3;o Paulo (UNIFESP) - S&#xE3;o Paulo
(SP), Brazil</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Hikawa RS, Kanehisa ES, Enokihara MMSS, Enokihara MY,
Hirata SH. Polypoid melanoma and superficial spreading melanoma - different
subtypes in the same lesion. An Bras Dermatol. 2014;89(4):666-8.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <collab>Seer.cancer.gov</collab>
            <name>
              <surname>Howlader</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Noone</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Krapcho</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Garshell</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Neyman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Altekruse</surname>
              <given-names>SF</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <comment>[Internet]</comment>
          <source>SEER Cancer Statistics Review, 1975-2010, National Cancer Institute.
Bethesda, MD, based on November 2012 SEER data submission, posted to the
SEER web site, April 2013</source>
          <date-in-citation content-type="access-date">Cited 2013 Jun 1</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://seer.cancer.gov/csr/1975_2010/">http://seer.cancer.gov/csr/1975_2010/</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGovern</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Mihm</surname>
              <given-names>MC</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Bailly</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Booth</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>WH</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Cochran</surname>
              <given-names>AJ</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The classification of malignant melanoma and its histologic
reporting</article-title>
          <source>Cancer</source>
          <year>1973</year>
          <volume>32</volume>
          <fpage>1446</fpage>
          <lpage>1457</lpage>
          <pub-id pub-id-type="pmid">4757934</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Breuninger</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>K&#xF6;hler</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Drepper</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bastian</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Br&#xF6;cker</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>G&#xF6;hl</surname>
              <given-names>J</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Is acrolentiginous melanoma (ALM) more malignant than
superficially spreading melanoma (SSM) at a high-risk site: a matched-pair
comparison between 113 ALM and SSM within the scope of a multicenter
study</article-title>
          <source>Hautarzt</source>
          <year>1994</year>
          <volume>45</volume>
          <fpage>529</fpage>
          <lpage>531</lpage>
          <pub-id pub-id-type="pmid">7960751</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balch</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Gershenwald</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Soong</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Atkins</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Byrd</surname>
              <given-names>DR</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Final version of 2009 AJCC melanoma staging and
classification</article-title>
          <source>J Clin Oncol</source>
          <year>2009</year>
          <volume>27</volume>
          <fpage>6199</fpage>
          <lpage>6206</lpage>
          <pub-id pub-id-type="pmid">19917835</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cutler</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Levin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallack</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Don</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Pedunculated malignant melanoma</article-title>
          <source>Dermatol Surg</source>
          <year>2000</year>
          <volume>26</volume>
          <fpage>127</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="pmid">10691940</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vogler</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Perdue</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Wilkins</surname>
              <given-names>SA</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>A clinical evaluation of malignant melanoma</article-title>
          <source>Surg Gynecol Obstet</source>
          <year>1958</year>
          <volume>106</volume>
          <fpage>586</fpage>
          <lpage>594</lpage>
          <pub-id pub-id-type="pmid">13556475</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGovern</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Milton</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Prognostic significance of polypoid configuration in malignant
melanoma</article-title>
          <source>Histopathology</source>
          <year>1983</year>
          <volume>7</volume>
          <fpage>663</fpage>
          <lpage>672</lpage>
          <pub-id pub-id-type="pmid">6629342</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Plotnick</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rachmaninoff</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>VandenBerg</surname>
              <given-names>HJ</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Polypoid melanoma: a virulent variant of nodular
melanoma</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1990</year>
          <volume>23</volume>
          <fpage>880</fpage>
          <lpage>884</lpage>
          <pub-id pub-id-type="pmid">2254474</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Giorgi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Massi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gerlini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mannone</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Quercioli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Carli</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Immediate local and regional recurrence after the excision of a
polypoid melanoma: tumor dormancy or tumor activation?</article-title>
          <source>Dermatol Surg</source>
          <year>2003</year>
          <volume>29</volume>
          <fpage>664</fpage>
          <lpage>667</lpage>
          <pub-id pub-id-type="pmid">12786716</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shaw</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Polypoid melanoma is not rare</article-title>
          <source>Br J Dermatol</source>
          <year>1996</year>
          <volume>135</volume>
          <fpage>333</fpage>
          <lpage>334</lpage>
          <pub-id pub-id-type="pmid">8881692</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
